ClinicaliQ Trial Snapshot
- N-WATCH: Nottingham Wheeze Assessment in Tidal Children — Recruiting • Respiratory / COPD / Asthma • NCT07833826.
- What is being tested: N-WATCH evaluates novel tidal breathing techniques for improved diagnosis and monitoring of long-term paediatric lung diseases, particularly asthma, as an alternative to standard assessment methods.
- Patient eligibility overview: The trial focuses on children with established long-term lung conditions requiring ongoing disease monitoring and management in UK healthcare settings.
Use This Page For
- Quick orientation before opening the registry record.
- Checking recruitment status, phase and sponsor at a glance.
- Connecting this trial to nearby guidelines, Drug Science and education.
What This Trial Is Studying
Children with long-term lung diseases like asthma need better techniques for diagnosis and monitoring of their disease. With better monitoring, it is anticipated that children and their carers will be able to manage their disease better, and be able to spot a deterioration in their condition sooner, leading to earlier intervention, for example to prevent an asthma attack. However, current devices which could be used at home are either too costly, require machines that are impractically large, or require specific breathing maneuvers which are unpopular with patients, or which are…
Eligibility Snapshot
- Workstream 1 inclusion criteria i) Aged 5 years or older, and less than 15 years plus 32 weeks of age ii) Participant has presented to hospital with acute wheeze, bronchospasm or asthma iii) Participant is not critically ill and is able to breathe into a mouthpiece for 90seconds. Workstream 2 inclusion criteria i) Participant 5 years or older, and less than 16 years of age. ii) Participant is due to have routine lung function testing.
Use the source registry for the full inclusion and exclusion criteria before discussing referral or enrolment.